Drugs / TAF
last change Sep 2025 re-read 2 minutes ago

TAF

Developed for
chronic hepatitis B virus infection

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT07307586 Comparator Sep 2025 → Dec 2026 expected chronic hepatitis B virus infection Zhigang Ren Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TAF ClinicalTrials.gov intervention name — accepted as the source's own label NCT07307586